Extended resection of non-small cell lung cancer invading the left atrium, is it worth the risk?

Autor:	Galvaing G; Department of Thoracic Surgery, Jean Perrin Comprehensive Cancer Center, 58 rue Montalembert, 63000 Clermont-Ferrand, France. geraud.galvaing@cjp.fr., Chadeyras JB; Department of Thoracic Surgery, Jean Perrin Comprehensive Cancer Center, Clermont-Ferrand, France., Merle P; Department of Pneumology, Gabriel Montpied University Hospital, Clermont-Ferrand, France., Tardy MM; Department of Thoracic Surgery, Jean Perrin Comprehensive Cancer Center, Clermont-Ferrand, France., Naamee A; Department of Thoracic Surgery, Jean Perrin Comprehensive Cancer Center, Clermont-Ferrand, France., Bailly P; Department of Thoracic Surgery, Jean Perrin Comprehensive Cancer Center, Clermont-Ferrand, France., Filaire M; Department of Thoracic Surgery, Jean Perrin Comprehensive Cancer Center, Clermont-Ferrand, France; Department of Anatomy, College of Medicine, Université d'Auvergne, Clermont-Ferrand, France.
Jazyk:	angličtina
Zdroj:	Chinese clinical oncology [Chin Clin Oncol] 2015 Dec; Vol. 4 (4), pp. 43.
DOI:	10.3978/j.issn.2304-3865.2015.06.08
Abstrakt:	Only few reports of surgical approach to T4 lung carcinoma invading the heart have been reported in the medical literature. It is also controversial if such cancer should be treated by surgery. The aim of this review is to assess the current risk/benefit ratio of the surgical management of non-small cell lung cancer (NSCLC) invading the left atrium, especially in the light of a multidisciplinary approach. We also expose our surgical experience and the procedure we have developed in order to increase our rate of complete resection as this criterion appears to be mandatory as well as patients' nodal status in order to increase life expectancy.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu